A. Simon Lynch

1.7k total citations
29 papers, 1.4k citations indexed

About

A. Simon Lynch is a scholar working on Infectious Diseases, Molecular Medicine and Molecular Biology. According to data from OpenAlex, A. Simon Lynch has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 15 papers in Molecular Medicine and 13 papers in Molecular Biology. Recurrent topics in A. Simon Lynch's work include Antibiotic Resistance in Bacteria (15 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). A. Simon Lynch is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). A. Simon Lynch collaborates with scholars based in United States, Bolivia and China. A. Simon Lynch's co-authors include Gregory T. Robertson, Zhenkun Ma, Timothy B Doyle, Robert K. Flamm, Todd A. Davies, Darren Abbanat, Brian J. Morrow, Karen Amsler, Anne Marie Queenan and Wenping He and has published in prestigious journals such as Journal of Bacteriology, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

A. Simon Lynch

29 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Simon Lynch United States 19 605 518 366 300 235 29 1.4k
Oliwia Makarewicz Germany 24 657 1.1× 528 1.0× 194 0.5× 146 0.5× 248 1.1× 70 1.8k
Simona Pollini Italy 25 756 1.2× 877 1.7× 493 1.3× 225 0.8× 223 0.9× 45 2.0k
Sandrine Lemaire Belgium 23 509 0.8× 464 0.9× 766 2.1× 406 1.4× 263 1.1× 43 1.5k
Matthias Willmann Germany 19 785 1.3× 562 1.1× 342 0.9× 239 0.8× 230 1.0× 41 1.8k
Sirijan Santajit Thailand 9 535 0.9× 570 1.1× 205 0.6× 129 0.4× 101 0.4× 19 1.4k
Matthias Marschal Germany 16 529 0.9× 323 0.6× 270 0.7× 197 0.7× 294 1.3× 31 1.4k
Céline Vidaillac United States 20 382 0.6× 354 0.7× 601 1.6× 357 1.2× 225 1.0× 43 1.2k
Stephen Rittenhouse United States 26 801 1.3× 812 1.6× 458 1.3× 607 2.0× 339 1.4× 43 2.2k
Dmitri Debabov United States 19 620 1.0× 227 0.4× 559 1.5× 300 1.0× 212 0.9× 42 1.5k
Aref Shariati Iran 22 665 1.1× 430 0.8× 420 1.1× 82 0.3× 218 0.9× 56 1.7k

Countries citing papers authored by A. Simon Lynch

Since Specialization
Citations

This map shows the geographic impact of A. Simon Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Simon Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Simon Lynch more than expected).

Fields of papers citing papers by A. Simon Lynch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Simon Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Simon Lynch. The network helps show where A. Simon Lynch may publish in the future.

Co-authorship network of co-authors of A. Simon Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of A. Simon Lynch. A scholar is included among the top collaborators of A. Simon Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Simon Lynch. A. Simon Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Zhenkun, Ying Yuan, Yu Liu, et al.. (2022). Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens. Journal of Medicinal Chemistry. 65(6). 4481–4495. 18 indexed citations
2.
Ding, Jun, Qian Zhang, Xiaomei Wang, et al.. (2020). Synergistic Activity of Nitroimidazole-Oxazolidinone Conjugates against Anaerobic Bacteria. Molecules. 25(10). 2431–2431. 9 indexed citations
3.
Chan, Rita, Peter T. Buckley, William E. Sause, et al.. (2019). Identification of biologic agents to neutralize the bicomponent leukocidins of Staphylococcus aureus. Science Translational Medicine. 11(475). 21 indexed citations
4.
Jordan, Robert E., Jeffrey Fernandez, Randall J. Brezski, et al.. (2016). A peptide immunization approach to counteract a Staphylococcus aureus protease defense against host immunity. Immunology Letters. 172. 29–39. 9 indexed citations
5.
Sause, William E., Peter T. Buckley, William R. Strohl, A. Simon Lynch, & Victor J. Torres. (2015). Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections. Trends in Pharmacological Sciences. 37(3). 231–241. 85 indexed citations
6.
Morrow, Brian J., Jennifer Deane, Daniel F. Sahm, et al.. (2013). Activities of carbapenem and comparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program. Diagnostic Microbiology and Infectious Disease. 75(4). 412–416. 40 indexed citations
7.
Abbanat, Darren, et al.. (2013). Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays. International Journal of Antimicrobial Agents. 43(1). 32–39. 31 indexed citations
8.
Davies, Todd A., Robert K. Flamm, & A. Simon Lynch. (2012). Activity of ceftobiprole against Streptococcus pneumoniae isolates exhibiting high-level resistance to ceftriaxone. International Journal of Antimicrobial Agents. 39(6). 534–538. 18 indexed citations
9.
Queenan, Anne Marie, Chris M. Pillar, Jennifer Deane, et al.. (2012). Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010. Diagnostic Microbiology and Infectious Disease. 73(3). 267–270. 65 indexed citations
10.
He, Wendy, Koné Kaniga, A. Simon Lynch, Robert K. Flamm, & Todd A. Davies. (2012). In vitro Etest synergy of doripenem with amikacin, colistin, and levofloxacin against Pseudomonas aeruginosa with defined carbapenem resistance mechanisms as determined by the Etest method. Diagnostic Microbiology and Infectious Disease. 74(4). 417–419. 14 indexed citations
11.
Davies, Todd A., Anne Marie Queenan, Brian J. Morrow, et al.. (2011). Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007–09. Journal of Antimicrobial Chemotherapy. 66(10). 2298–2307. 80 indexed citations
12.
Morrow, Brian J., Darren Abbanat, Ellen Z. Baum, et al.. (2011). Antistaphylococcal Activities of the New Fluoroquinolone JNJ-Q2. Antimicrobial Agents and Chemotherapy. 55(12). 5512–5521. 23 indexed citations
13.
Fernandez, Jeffrey, et al.. (2011). Efficacy of a New Fluoroquinolone, JNJ-Q2, in Murine Models of Staphylococcus aureus and Streptococcus pneumoniae Skin, Respiratory, and Systemic Infections. Antimicrobial Agents and Chemotherapy. 55(12). 5522–5528. 15 indexed citations
14.
Lynch, A. Simon & Darren Abbanat. (2010). New antibiotic agents and approaches to treat biofilm-associated infections. Expert Opinion on Therapeutic Patents. 20(10). 1373–1387. 41 indexed citations
15.
Hilliard, Jamese J., LeRoy Hall, Darren Abbanat, et al.. (2010). Comparative Effects of Carbapenems on Bacterial Load and Host Immune Response in aKlebsiella pneumoniaeMurine Pneumonia Model. Antimicrobial Agents and Chemotherapy. 55(2). 836–844. 16 indexed citations
16.
Li, Jing, et al.. (2007). Preparation and in vitro anti-staphylococcal activity of novel 11-deoxy-11-hydroxyiminorifamycins. Bioorganic & Medicinal Chemistry Letters. 17(20). 5510–5513. 14 indexed citations
17.
Lynch, A. Simon & Gregory T. Robertson. (2007). Bacterial and Fungal Biofilm Infections. Annual Review of Medicine. 59(1). 415–428. 351 indexed citations
18.
Combrink, Keith D., Zhenkun Ma, Dalai Yan, et al.. (2006). New C25 carbamate rifamycin derivatives are resistant to inactivation by ADP-ribosyl transferases. Bioorganic & Medicinal Chemistry Letters. 17(2). 522–526. 30 indexed citations
19.
Lynch, A. Simon. (2005). Efflux systems in bacterial pathogens: An opportunity for therapeutic intervention? An industry view. Biochemical Pharmacology. 71(7). 949–956. 77 indexed citations
20.
Li, Jing, In Ho Kim, Eric Roche, et al.. (2005). Design, synthesis, and biological evaluation of BODIPY®–erythromycin probes for bacterial ribosomes. Bioorganic & Medicinal Chemistry Letters. 16(4). 794–797. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026